What You Should Know:
- Doceree, the leading global network of physician-only platforms for programmatic messaging, announced a USD 35 million Series B round led by Creaegis, the leading digital and technology investment firm.
- Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the round.
Series Funding Set to Empower Pharmaceutical and Life Sciences Companies
With a mission to revolutionize global healthcare professional (HCP) marketing, Doceree will use the funds to expedite product development, enhance technologies, expand globally, and grow the team. Founded in 2019, Doceree empowers pharmaceutical and life sciences companies, as well as healthcare media agencies, by seamlessly connecting with HCPs within their digital workflows to improve patient health outcomes. The company, boasting the world’s largest HCP-exclusive digital platform network, has quickly advanced HCP communications through programmatic messaging, aiding clients worldwide in optimizing physician engagement initiatives.
“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain MD, Founder & Global CEO, Doceree. Jain further added, “We are growing massively and have competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space.”
Doceree has grown more than 100% in the last one year with monthly revenue rising five folds between the Series A funding in April 2022 and now. The company has introduced category-first innovations on the demand and supply sides, including Doceree Enterprise, an HCP-focussed global Demand Side Platform (DSP), and Doceree Provider that empowers HCPs to improve health outcomes of their patients. Its HCP marketing ecosystem consists of custom-built solutions that equip life science marketers to engage with physicians at opportune moments with contextual messaging and evaluate campaign performances to improve script lift.
